Loading...
Loading...
Application UK00909272113 · Registered
| Application Number | UK00909272113 |
| Status | Registered |
| Owner | Veracyte, Inc. |
| Filed | 2010-07-26 |
| Registered | 2015-05-29 |
| Renewal Due | 2030-07-26 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. AFIRMA is currently a registered UK trademark, with renewal due on 2030-07-26. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Scientific research and development services in the fields of oncology, the treatment of cancer and cancer diagnostics; pharmaceutical research in the fields of pharmaceutical preparations used in the diagnosis and treatment of cancer; drug and pharmaceutical discovery; scientific research and development services in the field of oncology and the treatment and diagnosis of cancer and immune diseases; development of pharmaceuticals, biopharmaceutical preparations, vaccines, immunotherapy agents and biologics for others; medical and pharmaceutical research services; creation, updating and hosting of a website providing information in the field of oncology and the diagnosis and treatment of cancer; technical help and support services provided by telephone or electronic mail and relating to diagnostic testing; information and advisory services relating to the aforesaid provided online over the internet or extranets.
Medical diagnostic testing services; information and advisory services relating to cancer diagnostics, oncology, and pharmaceuticals, including such services provided on-line from a computer network or the Internet; testing for diagnostic or treatment purposes; medical services, namely treatment of human diseases and disorders; medical consulting services; human medical and prognostic testing services; providing a database in the field of human diseases, and adapted for the inputting and collection of data and information all for treatment and diagnostic purposes; providing medical information; medical diagnostic, theranostic, prognostic and analysis services; medical diagnostic testing, monitoring and reporting services; medical services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumour profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes; information and advisory services relating to the aforesaid provided online over the internet or extranets.
'AFIRMA' is a registered trademark on the UK IPO register, owned by Veracyte, Inc.. The application (UK00909272113) was filed on 26 July 2010 and registered on 29 May 2015. The registration is set to expire on 26 July 2030.
This mark is recorded under multiple classes: Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by CMS Cameron McKenna Nabarro Olswang LLP.
UK trademark UK00909272113 for the mark 'AFIRMA' in Class 42, 44 is recorded on the UK IPO register as owned by Veracyte, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00909272113 for the mark 'AFIRMA' as registered.
UK trademark UK00909272113 for the mark 'AFIRMA' is recorded in Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 42: Scientific research and development services in the fields of oncology, the treatment of cancer and cancer diagnostics; pharmaceutical research in the fields of pharmaceutical preparations used in the diagnosis and treatment of cancer; drug and pharmaceutical discovery; scientific research and development…
UK trademark UK00909272113 for the mark 'AFIRMA' was filed at the UK IPO on 26 July 2010 and registered on 29 May 2015.
UK trademark UK00909272113 for the mark 'AFIRMA' is currently recorded as valid until 26 July 2030, at which point it will need to be renewed with the UK IPO to remain in force.
CMS Cameron McKenna Nabarro Olswang LLP is listed as the attorney / representative of record for UK trademark UK00909272113 for the mark 'AFIRMA' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "AFIRMA" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| AFIRMASame applicant | 77925349 | 800 | 2010-02-01 |
| AFIRMA GROUP | 86068188 | 602 | 2013-09-18 |
| AFIRMA | 86059088 | 800 | 2013-09-09 |
| BIO-AFIRMA | 73361735 | 602 | 1982-04-26 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| AFIRMACIÓN AÑEJO | 88099903 | 602 | 2018-08-30 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.